• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human KCNJ5 Polyclonal Antibody

The antibody against KCNJ5 was raised in rabbit using the Synthesized peptide derived from the C-terminal region of Human KIR3.4. as the immunogen. This antibody exists as a non-conjugated isotype IgG. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been validated on WB, IF, ELISA.

ADC-32932A

The antibody against KCNJ5 was raised in rabbit using the Synthesized peptide derived from the C-terminal region of Human KIR3.4. as the immunogen. This antibody exists as a non-conjugated isotype IgG. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been validated on WB, IF, ELISA.

$167.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-32932A ClonalityPolyclonal
Host SpeciesRabbitTarget NameKCNJ5
Target Synonymsinwardly rectifying subfamily J member 5, KCNJ5; GIRK4; G protein-activated inward rectifier potassium channel 4; GIRK-4; Cardiac inward rectifier; CIR; Heart KATP channel; Inward rectifier K(+ channel Kir3.4; IRK-4; KATP-1; Potassium channelFormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer0.5% BSA and 0.02% sodium azide., Liquid in PBS containing 50% glycerolPurification MethodThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
ConjugateNon-conjugatedApplicationELISA, IF, WB
StorageUpon receipt

Immunogen Information


Immunogen DescriptionSynthesized peptide derived from the C-terminal region of Human KIR3.4.Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDP48544
Background Information
  • Uniprot Id

    P48544

  • Target Species

    Human

  • Target Name

    KCNJ5

  • Target Full Name

    G protein-activated inward rectifier potassium channel 4

  • Target Function

    This potassium channel is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by external barium.

  • Target Involvement

    Long QT syndrome 13 (LQT13); Hyperaldosteronism, familial, 3 (HALD3)

  • Target Subcellular Location

    Membrane; Multi-pass membrane protein.

  • Target Protein Families

    Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ5 subfamily

  • Target Tissue Specificity

    Islets, exocrine pancreas and heart. Expressed in the adrenal cortex, particularly the zona glomerulosa.

  • Target Synonyms

    KCNJ5; GIRK4; G protein-activated inward rectifier potassium channel 4; GIRK-4; Cardiac inward rectifier; CIR; Heart KATP channel; Inward rectifier K(+ channel Kir3.4; IRK-4; KATP-1; Potassium channel, inwardly rectifying subfamily J member 5

  • Target Background

    This gene encodes an integral membrane protein which belongs to one of seven subfamilies of inward-rectifier potassium channel proteins called potassium channel subfamily J. The encoded protein is a subunit of the potassium channel which is homotetrameric. It is controlled by G-proteins and has a greater tendency to allow potassium to flow into a cell rather than out of a cell. Naturally occurring mutations in this gene are associated with aldosterone-producing adenomas.

Inquire Rabbit anti-Human KCNJ5 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification